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1430Objectives: To assess root replacement and annular stabilization in bicuspid aortic valve repair, we compared
results of reimplantation technique versus subcommissural annuloplasty or no annuloplasty.
Methods: Between 1995 and 2010, 161 consecutive patients underwent bicuspid aortic valve repair. Patients
undergoing subcommissural annuloplasty or no annuloplasty (group 1, n ¼ 87) had larger root dimensions
and less aortic insufficiency than did patients undergoing reimplantation technique (group 2, n ¼ 74). We
matched groups 1 to 1 on basis of those criteria. After matching (n ¼ 106, n ¼ 53 per group), root dimensions
(41.5 5 vs 40 4 mm; P¼ .2) and degree of insufficiency (2.6 1.2 vs 2.7 1; P¼ .6) were similar between
groups.
Results: Techniques of cusp repair were similar between groups. Group 2 had smaller preoperative left ventric-
ular size (P¼ .02), fewer concomitant procedures (P¼ .02), and shorter follow-up (41 30 vs 63 40 months;
P ¼ .003). There were no in-hospital deaths. At discharge, residual aortic insufficiency was similar between
groups, but peak gradient greater than 25 mm Hg was more frequent in group 1 (13% vs 30%; P ¼ .04). At 6
years, overall survivalwas 98% 3% in both groups. Freedoms from reoperation and aortic insufficiency greater
than 2þwere significantly better in group 2 (100% vs 90%  8%; P ¼ .03; 100% vs 77%  14%; P ¼ .002).
Conclusions: In bicuspid aortic valve repair, root replacement with the reimplantation technique stabilizes the
ventriculoaortic junction, improves valve mobility (low gradient), and is associated with improved outcomes.
(J Thorac Cardiovasc Surg 2011;142:1430-8)Bicuspid aortic valve (BAV) is the most common congenital
cardiac anomaly in the adult population.1 Although BAV
disease can occasionally be associated with normal lifelong
valve function, its presence is associated with a risk of early
degeneration leading to aortic insufficiency (AI), stenosis,
or aneurysm starting in the third decade of life.2 Flow distur-
bances and intrinsic abnormalities of aortic valve and aortic
wall tissues are implicated in the degenerative process.3
In the setting of BAV insufficiency, valve repair has been
performed during the last 2 decades with the goal of avoid-
ing prosthetic valve–related complications in this young
population. BAV repair is considered to be a valid alterna-
tive to replacement, with an 8- to 10-year reoperation rate
ranging from 15% to 20%.4-6 The main reason for
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The Journal of Thoracic and Cardiovascular Surthan 90% of patients requiring reoperation.5,6 Other than
the obvious mechanisms of failure, such as leaflet suture
dehiscence, the causes of recurrent AI are rarely reported.
In our own series, we have observed technical
complications such as suture dehiscence but we have also
observed late failures from recurrent cusp prolapse, which
can occur as a result of changes in the size and
morphology of the aortic root and the functional aortic
annulus.5 In this context, the nature of annuloplasty at the
time of the initial repair can have important prognostic im-
plications for repair durability. The functional aortic annu-
lus, consisting of the ventriculoaortic junction (VAJ) and
sinotubular junction (STJ), is best stabilized by performing
a valve-sparing root replacement with the reimplantation
technique. In the setting of a nondilated aortic root, how-
ever, the indications for this more invasive procedure in
BAV repair remain controversial. In this study, we com-
pared the results of BAV repair with the reimplantation
technique with those of BAV repair with subcommissural
annuloplasty or no annuloplasty.MATERIALS AND METHODS
This study was approved by the ethics review board of the hospital.
Written informed consent was waived for this study.
Group Selection and Matching
Between December 1995 and June 2010, a total of 161 consecutive pa-
tients with BAVunderwent nonemergency valve preservation and repair forgery c December 2011
Abbreviations and Acronyms
AI ¼ aortic insufficiency
BAV ¼ bicuspid aortic valve
IQR ¼ interquartile range
STJ ¼ sinotubular junction
VAJ ¼ ventriculoaortic junction
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DAI or aortic aneurysm. Interventions on the aortic annulus (the VAJ) in this
population included no annuloplasty, subcommissural annuloplasty with or
without supracoronary ascending aorta replacement, valve-sparing root re-
placement with the reimplantation technique, or use of the remodeling
technique (noVAJ annuloplasty). These patients were divided into 2 groups
on the basis of the type of VAJ annuloplasty (Figure 1). Patients who un-
derwent repair with no annuloplasty, subcommissural annuloplasty, or
the valve-sparing procedure with the remodeling technique (n ¼ 87)
were compared with patients who underwent repair with the valve-
sparing procedure with the reimplantation technique (n¼ 74). Comparison
of preoperative characteristics revealed that patients undergoing the valve-
sparing procedure with the reimplantation technique had larger root diam-
eter (sinus of Valsalva, 44 8 mm vs 38 5 mm; P<.001), less AI (mean
AI, 28 1 vs 25  1; P ¼ .04), and later operation (mean follow-up, 71 
43 months vs 40  33 months; P<.001). Because root diameter and AI
clearly influenced the selection of operative technique, we matched pa-
tients 1:1 on the basis of these 2 variables in a hierarchic fashion (maximum
aortic root diameter followed by preoperative AI). Maximum aortic root di-
ameter and AI, as assessed by preoperative echocardiography, were catego-
rized as follows: diameter less than 35mm, 36 to 40mm, 41 to 45mm, 46 to
50 mm, or greater than 51 mm, and AI grade 0 to 2þor at least 3þ. This pro-
cess resulted in 53matched pairs (total n¼ 106), and their preoperative and
intraoperative characteristics are listed in Table 1.
Surgical Techniques
Techniques of aortic valve repair and the surgical approach to BAV re-
pair have been previously described.5 The subcommissural annuloplasty
was generally performed at each commissure of the valve with
polytetrafluoroethylene-reinforced braided sutures. The U-shaped suture
was passed horizontally through the aortic wall from one side of the com-
missure to the other. The annuloplasty was performed at the half of inter-
leaflet triangle height or lower to obtain greater plication. Supracoronary
ascending aorta replacement was performed with a straight Dacron polyes-
ter fabric tube sized on the STJ that corresponded to good cusp coaptation.
Root remodeling was performed with a straight Dacron polyester fabric
tube similarly sized. In patients presenting with dilatation of a single sinus
only (generally the noncoronary sinus), partial root remodeling was per-
formed. During the study period, root remodeling has been progressively
less used in favor of the reimplantation technique. Subcommissural annu-
loplasty was frequently associated with supracoronary ascending aorta
replacement and root remodeling to increase cusp coaptation and stabilize
the VAJ.
Of importance for this study is that during the study period we expanded
the indications for root replacement with the reimplantation technique in the
setting of BAV repair. This evolution toward a lower threshold of aortic size
to perform reimplantation was motivated in part by the change in the recent
guidelines as well as from our own experience. For the reimplantation tech-
nique, root dissection is performed deep to the level of cusp insertion. The
prosthesis is tied down proximally with 12 polytetrafluoroethylene-
reinforced braided sutures passed under the cusps all around the valve
circumference (Figure 1,B).7 Since 2002, the Gelweave Valsalva graft (Vas-
cutek Ltd, a Terumo Company, Renfrewshire, Scotland) has progressively
replaced the Dacron polyester fabric tube graft in the reimplantationThe Journal of Thoracic and Cartechnique. Initially, the graft was sized on the basis of the STJ size that cor-
responded to good cusp coaptation, a value to which we added 4 to 5 mm to
obtain prosthesis diameter. During the past 2 years, we have changed our
method, andwe now actuallymeasure the height of the commissure between
the noncoronary and the left coronary sinuses,which corresponds to thegraft
diameter.8
The repair techniques to manage conjoint cusp raphe consisted of shav-
ing (eg, in case of rudimentary raphe), resection, and direct closure, or of
resection and repair with a pericardial patch. Cusp prolapse was treated
by free margin central plication or by free margin resuspension with a run-
ning suture of polytetrafluoroethylene.9 Cusp perforation was repaired with
a pericardial patch. In the absence of root replacement, cusp repair was gen-
erally performed first, followed by subcommissural annuloplasty and then
by the supracoronary ascending aorta replacement when necessary. When
root replacement was planned, raphe or cusp perforation was repaired first,
and then the root replacement was performed. After root replacement, cusp
coaptation was reevaluated, and any residual cusp prolapse was corrected.
Echocardiographic Assessment
After repair, transesophageal echocardiography was performed in all
patients to assess the degree of residual AI, orientation of the regurgitant
jet (if present), and the coaptation length and height. Coaptation length
of at least 5 mm at the midportion of the free margin or a coaptation height
above the aortic valve annulus were prerequisites for a successful repair,
and the presence of an eccentric residual AI jet was an indication for reex-
ploration of the aortic valve.10
Follow-up
Clinical follow-up was conducted through outpatient visits or as tele-
phone follow-up by a research nurse. Information on survival status and
valve-related complications, including thromboembolism, hemorrhage,
endocarditis, reoperation, and cardiovascular symptoms, was obtained as
defined in published guidelines. Transthoracic echocardiography was per-
formed in all patients before discharge and at regular intervals during
follow-up. The closing interval for the study was between September
2010 and December 2010. Clinical follow-up (median, 52 months; inter-
quartile range [IQR], 18–91 months) and echocardiographic follow-up
(median, 46 months; IQR, 17–81 months) were complete in 99% and
98% of cases, respectively.
Statistical Analyses
Continuous data are presented as mean  SD, or as median with IQR,
for nonparametric data. Failure time data on survival, reoperation, and re-
current AI are presented with Kaplan-Meier survival curves. Patients un-
dergoing aortic valve rerepair were not reentered into the database for
calculation of reoperation-free survival. The date of the first diagnosis of
recurrent AI greater than grade 2þwas recorded for time-to-event calcula-
tion. Comparisons between groups for failure time data were performed
with the log-rank test. Statistical analyses were performed with the SAS
version 9.1 statistical software package (SAS Institute, Inc, Cary, NC).
Graphs were constructed with GraphPad Prism 5.0 (GraphPad Software,
Inc, La Jolla, Calif).
RESULTS
Preoperative and Intraoperative Data
Table 1 compares the preoperative and intraoperative
data between groups 1 and 2. Except for slightly larger
left ventricular dimensions in group 1, preoperative vari-
ables were similar in the matched groups. Notably, the spe-
cific variables used for matching, severity of AI and root
diameter (sinus of Valsalva), showed similar distribution
andmean value, respectively, in matched groups. The othersdiovascular Surgery c Volume 142, Number 6 1431
FIGURE 1. Definition of the study groups. BAV, Bicuspid aortic valve; VAJ, ventriculoaortic junction; SCA, subcommissural annuloplasty. 1Root remod-
eling was performed with replacement of a single sinus of Valsalva (partial remodeling) in 14 patients and with replacement of both sinuses (complete re-
modeling) in 3 patients. 2Reimplantation was performedwith Dacron polyester tube graft in 23 patients (31%) and with a GelweaveValsalva graft (Vascutek
Ltd, a Terumo Company, Renfrewshire, Scotland) in 51 patients (69%). A, Illustration of subcommissural annuloplasty suture (black arrow). B, Illustration
of proximal circumferential suture line (white arrows) in reimplantation technique.
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Ddimensions of the proximal aorta (VAJ, STJ, and ascending
aorta) were also similar between groups.
Aortic cusp repair was performed frequently and in sim-
ilar proportions in both groups (98% vs 93%; P¼ .36), and
the different techniques used for cusp repair were similarly
used in both groups. The need for aortic valve reexploration
was also similar between groups. Finally, a higher rate of
concomitant procedures was observed in group 1 (21% vs
4%; P ¼ .018), and a longer procedure time was observed
in group 2 (P<.001).Early Outcomes
In the entire cohort, there were no in-hospital deaths.
Aortic valve repair–related complications are listed in
Table 2. There were no significant differences in term of re-
operation for bleeding, permanent pacemaker implantation,
and stroke between groups. Early aortic valve reoperation
was necessary for 4 patients from group 1 (7.5%; days 6,
7, 10, and 12) and none from group 2. These cases occurred
early in our experience, and the causes of repair failure were
largely technical, including cusp perforation, suture dehis-
cence, cusp prolapse, and fistula between the aortic root
and the right ventricle. Of those patients undergoing
aortic valve reoperation, 3 underwent aortic valve rerepair
and one underwent a Ross procedure. On discharge echo-
cardiography, residual AI was similar in both groups. Group1432 The Journal of Thoracic and Cardiovascular Sur1 presented with significantly higher transvalvular peak gra-
dient than did group 2.Clinical Follow-up
Clinical follow-up was complete in 100% and 98% of
cases in groups 1 and 2, respectively. Patients from group
1 had longer clinical follow-up (median, 50 months; IQR,
26–96 months) than did those from group 2 (median, 34
months; IQR, 13–63 months). One patient died in each
group; the cause of death was unknown in the patient
from group 1, whereas the cause in the patient from group
2 was congestive heart failure after reoperation for coronary
surgery with a normally functioning aortic valve. At 6 years,
overall survival was 98%  3% in both groups (Figure 2,
A). Late reoperations were necessary in 3 patients from
group 1 (2 recurrent AI, 1 endocarditis) after 23, 76, and
120 months. At 6 years, freedoms from aortic valve reoper-
ation, including early reoperation, were 90%  8% in
group 1 and 100% in group 2 (P ¼ .025; Figure 2, B).
Two patients in group 1 had endocarditis; 1 of these un-
derwent aortic valve reoperation (as described in the next
paragraph), and 1 of these was treated medically. At last
follow-up, New York Heart Association functional class I,
II, or III symptoms were present in 83%, 17%, and 0%, re-
spectively, of patients in group 1 and in 86%, 12%, 2%, re-
spectively, of patients in group 2 (P ¼ .3).gery c December 2011
TABLE 2. Early postoperative outcomes within matched groups
Group 1
(n ¼ 53)
Group 2
(n ¼ 53)
P
value
Postoperative outcomes
Mortality 0 0 —
Reoperation for bleeding 6 (11%) 7 (13%) >.999
Aortic valve reoperation 4 (7.5%) 0 .13
Permanent pacemaker insertion 2 (4%) 4 (8%) .67
Stroke or transient ischemic attack 2 (4%) 2 (4%) >.999
Discharge echocardiography*
Aortic insufficiency grade
0 26 (53%) 32 (62%)
1 20 (41%) 19 (36%) .46
2 3 (6%) 1 (2%)
Peak gradient
20 mm Hg 25 (51%) 42 (81%)
21–30 mm Hg 14 (29%) 7 (13%) .006
>30 mm Hg 10 (20%) 3 (6%)
All data represent numbers and percentages of patients. *Early reoperation excluded.
TABLE 1. Preoperative patient characteristics and intraoperative
data within matched groups
Group 1
(n ¼ 53)
Group 2
(n ¼ 53)
P
value
Age (y, mean  SD) 47  11 44  11 .13
Male (no.) 49 (93%) 50 (94%) >.999
New York Heart Association
functional class (no.)
.12
1 21 (40%) 30 (57%)
>1 32 (60%) 23 (43%)
Previous cardiac surgery (no.) 0 (0%) 1 (2%) >.999
Aortic insufficiency grade (no.) .58
1 8 (15%) 13 (25%)
2 12 (23%) 7 (13%)
3 22 (42%) 20 (38%)
4 11 (21%) 13 (25%)
LV end-systolic diameter
(mm, mean  SD)
41  10 38  7 .02
LV end-diastolic diameter
(mm, mean  SD)
61  9 58  7 .03
LV ejection fraction (no.) .36
>50% 45 (85%) 49 (92%)
<50% 8 (15%) 4 (8%)
Aortic diameter (mm, mean  SD)
Ventriculoaortic junction 27  3 28  3 .18
Sinuses of Valsalva 40  4 41.5  5 .18
Sinotubular junction 36  5 37  5 .34
Ascending aorta 44  8 45  7 .35
Aortic cusp repair (no.)
All 52 (98%) 49 (93%) .36
Raphe shaving 11 (21%) 12 (23%) >.999
Raphe resection and primary
closure
23 (43%) 20 (38%) .69
Raphe resection and patch
repair
9 (17%) 6 (11%) .40
Cusp prolapse repair 42 (79%) 41 (77%) >.999
Patch repair for cusp
perforation
3 (6%) 3 (6%) >.999
Any patch repair 12 (23%) 9 (17%) .47
Functional aortic annuloplasty (no.)
SCA 24 (45%) —
Ascending aorta replacement 3 (6%) —
Ascending aorta replacement
plus SCA
12 (23%) —
Valve-sparing remodeling* 4 (7%) —
Valve-sparing remodeling*
plus SCA
10 (19%) —
Valve-sparing reimplantation — 53 (100%)
Intraoperative aortic valve
reexploration (no.)
4 (8%) 1 (2%) .36
Concomitant proceduresy (no.) 11 (21%) 2 (4%) .02
Cardiopulmonary bypass time
(min, mean  SD)
94  31 131  24 <.001
Aortic crossclamp time
(min, mean  SD)
73  24 113  22 <.001
LV, Left ventricular; SCA, subcommissural annuloplasty. *Replacement of a single si-
nus of Valsalva only (partial remodeling, n ¼ 13) or replacement of both sinuses
(complete remodeling, n ¼ 1). yConcomitant procedures were mitral valve repair
(n¼ 4), coronary artery bypass grafting (n¼ 5), and aortic arch replacement (n¼ 4).
de Kerchove et al Acquired Cardiovascular Disease
The Journal of Thoracic and Car
A
C
DEchocardiographic Follow-up
Echocardiographic follow-up was complete for 98% of
patients in both groups. Patients from group 1 had longer
echocardiographic follow-up (median, 48 months; IQR,
21–84 months) than did those from group 2 (median, 32
months; IQR, 11–63 months). At 6 years, freedoms from
AI greater than 2þ were 77%  14% in group 1 and
100% in group 2 (P ¼ .002). Freedoms from AI greater
than 1þwere 64%  15% in group 1 and 95%  5% in
group 2 (P ¼ .0006; Figure 2, C and D).
Mean transvalvular gradient greater than 40 mm Hg was
observed in 2 patients from group 1 and in 1 patient from
group 2 after 97, 143, and 83 months, respectively. All 3 pa-
tients were free of symptoms at last follow-up.
Mechanisms of Repair Failure in Late Reoperations
(Unmatched)
In the entire cohort (n ¼161), a total of 9 patients under-
went late aortic valve reoperation after a mean follow-up
time of 73  30 months (Table 3). All those patients were
from (unmatched) group1, and the reasons for reoperation
were recurrent AI (n¼ 7), endocarditis (n¼ 1), and stenosis
(n¼ 1). In the patients with AI, echocardiographic analysis
and intraoperative findings revealed that cusp prolapse asso-
ciated with VAJ dilatation was the principal mechanisms of
recurrent AI (Figure 3). With complete echocardiography
available in 7 patients undergoing late reoperation, compar-
ison between early postoperative and preredo VAJ diameter
values showed a mean increase of 4.4  0.5 mm (P<.001)
during a mean interval of 5  3 years. The details of reop-
erations are listed in Table 3.
DISCUSSION
Although valve repair for BAV insufficiency is consid-
ered an acceptable alternative to replacement; repair failure,diovascular Surgery c Volume 142, Number 6 1433
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FIGURE 2. Kaplan-Meier actuarial survival curves comparing group 1 and group 2. A, Overall survival (P¼ .9). B, Freedom from aortic valve reoperation
(P ¼ .025). C, Freedom from recurrent aortic insufficiency greater than 2þ (P ¼ .002). D, Freedom from recurrent aortic insufficiency greater than 1þ
(P ¼ .0006).
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Dlargely caused by recurrent AI, remains the principal con-
cern that limits application of this technique. In this study,
we demonstrated that valve-sparing root replacement with
the reimplantation technique can significantly increase du-
rability of BAV repair without additional morbidity relative
to less aggressive annuloplasty. The lower immediate post-
operative transvalvular gradients suggest increased valve
mobility after reimplantation in comparison with the other
techniques. Furthermore, echocardiographic review ofTABLE 3. Details of late bicuspid aortic valve reoperations (unmatched)
Bicuspid
AV repair
Redo
delay (y)
Functional
AA plasty
Raphe
repair
Other cusp
repair techniq
1996 8 AA replacement Primary closure Decalcification
2000 7 SCA Shaving FMP, FMR
2001 2 SCA Patch —
2001 10 SCA Shaving FMR
2002 6 SCA Primary closure FMR
2002 6.5 Remodeling, SCA — FMP
2002 6.5 SCA Primary closure FMR
2003 6.5 SCA Patch —
2007 2 SCA — FMP, FMR, pa
on perforatio
AV,Aortic valve; AA, aortic annulus; VAJ, ventriculoaortic junction; NA, not available; AS, a
margin plication; FMR, free margin resuspension (with running suture of polytetrafluoroeth
millimeters) on long-axis view, measures were taken on postrepair and preredo transesopha
ventriculoaortic junction.
1434 The Journal of Thoracic and Cardiovascular Surrepair failures confirms that the VAJ can dilate years after
subcommissural annuloplasty.
Despite critiques on the nonphysiologic cusp motion and
potential cusp damage caused by the elimination of the Val-
salva sinuses, the reimplantation technique is associated
with excellent valve durability and long-term out-
comes.11,12 Moreover, the type of graft (eg, Valsalva
graft) and the techniques used actually can recreate the
Valsalva sinuses in shape and improve cusp motion.12-14ue
VAJ
postop*
VAJ
redo*
VAJ
differencey
Failure
mechanism
Type of AV
reoperation
NA 23 NA AS Bioprosthesis
NA 23 NA AI and AS Bioprosthesis
20 24 4 AI, prolapse Ross
27 32 5 AI, prolapse Rerepair
reimplantation
21 25 4 AI, prolapse Ross
19 23 4 AI, endocarditis Rerepair
24 29 5 AI, prolapse Rerepair
reimplantation
24 29 5 AI, prolapse Bioprosthesis
tch
n
28 32 4 AI, prolapse Bioprosthesis
ortic stenosis; SCA, subcommissural annuloplasty; AI, aortic insufficiency; FMP, free
ylene 7/0). *Echocardiographic measures of the ventriculoaortic junction diameter (in
geal echocardiography. yDifference between postoperative and follow-up measures of
gery c December 2011
FIGURE 3. Illustration of ventriculoaortic junction redilatation in a 30-year-old man undergoing bicuspid aortic valve repair with subcommissural annu-
loplasty, raphe resection and direct closure, and resuspension of both cusps with polytetrafluoroethylene. Echocardiographic long-axis views show the ven-
triculoaortic junction diameter (arrows) before bicuspid aortic valve repair (A, 29 mm), after bicuspid aortic valve repair (B, 24 mm), and 6.5 years later,
before bicuspid aortic valve reoperation for recurrent aortic insufficiency (C, 29 mm).
de Kerchove et al Acquired Cardiovascular Disease
A
C
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reimplantation technique in BAV repair even for patients
with mild to moderate root dilatation. The stability
through time of the VAJ annuloplasty performed in
the reimplantation technique probably explains the
differences observed between the 2 groups. VAJ
dilatation is common in BAV, and a proportional
relationship has been shown with the degree of
regurgitation.6,15 We observed recurrent dilatation of VAJ
after subcommissural annuloplasty in patients needing
reoperation. Similarly, Aicher and associates. have found,
among others factors, both the preoperative VAJ diameter
and subcommissural annuloplasty independent predictors
of BAV repair failure.
The better durability observed in the reimplantation tech-
nique may not be only due to the VAJ annuloplasty offered
by this technique. Effectively, we observed after the reim-
plantation technique lower transvalvular gradient in com-
parison to group 1. This observation, resulting from
improved cusps mobility, is related to the functional aortic
annulus (VAJ plus STJ) and valve reshaping during reim-
plantation. During the past 2 years, we fashioned the VAJ
annuloplasty during the reimplantation procedure in such
a way as to reduce the base of implantation of the conjoint
cusp. This technique makes the valve more symmetric and
decreases cusp tension, which is of particular interest after
raphe resection. As such, decreased cusp tension allows in
certain cases to perform direct closure instead of cusp ex-
tension with pericardial patch, which is a predictor of repair
failure.
In BAV repairs, Aicher and colleagues6 have also re-
ported a better durability with valve-sparing surgery, but
with the remodeling technique. This suggests that both
valve-sparing procedures exert several beneficial effects
on the repair. One is a better stabilization of the functional
aortic annulus, and another is the potential to improveThe Journal of Thoracic and Carthe valve configuration during surgery. We have concerns,
however, about the absence of VAJ annuloplasty in the re-
modeling technique. Effectively, it may be responsible for
late AI recurrence as reported by some, especially in
patients with VAJ dilatation.12,16 For this reason, those
who routinely use the remodeling technique actually
recommend the addition of a VAJ annuloplasty.6,17
During the study period, we have increased our indica-
tions to perform root replacement with the valve reimplan-
tation technique. Our motives were principally related to
pathoanatomic changes present in BAV disease. In addition
to the dilatation of the root and ascending aorta, tissues gen-
erally present with increased fragility, and locally the wall
of the Valsalva sinuses may be particularly thin. This last
feature is best observed at the bases of the right and the non-
coronary sinuses, where the aortic wall appears translucent
with sometimes a localized aneurysmal appearance. Thin-
ning of the sinuses does not always seem proportional to
the severity of root dilatation, and it may be associated
with distal migration of the coronary ostia. The aortic
wall thinning and fragility should be considered as the mac-
roscopic expression of histologic and molecular abnormal-
ities observed in the aortic media of patients with BAV.3,18 It
has not been reported how thinning specifically affects
patient outcome, but in our experience, it may be a source
of both intraoperative complications (eg, wall perforation
with subcommissural annuloplasty stitches) and late
complications (eg, progressive dilatation of the VAJ and
recurrent AI).
In patients with BAV, guidelines recommend aortic re-
placement for aortic diameter greater than 50 mm in the ab-
sence of valve dysfunction and 45 mm in the setting of
concomitant valvular surgery.19 However, regarding litera-
ture data, the thresholds for aortic replacement remains con-
troversial.20-24 Data from the international registry of acute
aortic dissection show that approximately 20% of type Adiovascular Surgery c Volume 142, Number 6 1435
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Ddissections occur with aortic diameter smaller than
45 mm20; considering BAV only, however, this prevalence
seems to drop below 5%.24 In a large retrospective review
of outcomes after BAV surgery, Svensson and associates22
have reported a very low risk of aortic events after midterm
follow-up (mean 6 years) in patient with aortic diameter
smaller than 45 mm at surgery. In similar patients, Borger
and colleagues21 have reported a relatively high rate of
20% of ascending aorta complications after 15 years of
follow-up. In our surgical practice, we have expanded the
indication for root replacement in BAV with the objective
of improving immediate and long-term results of BAV re-
pair, and not with the intent to prevent the aortic complica-
tions related to BAV aortopathy. Consequently, these
indications are not applied for BAV replacement. Moreover,
we were able to maintain low mortality and morbidity with
this aggressive root replacement approach. In comparison
with patients from group 1, these patients showed a higher
rate of permanent pacemaker implantation after the reim-
plantation technique (8% vs 4%; P ¼ .67); however, the
4.8% rate of pacemaker implantation in our global experi-
ence with the reimplantation technique is probably a more
representative number.
In patients presenting with recurrent AI, the choice of re-
repair versus replacement is not simply a technical surgical
decision but also takes into account patient age, comorbid-
ities, and, most importantly, the patient’s wishes regarding
another attempt at repair. Because our understanding of
the mechanism of failure in these patients has improved,
we can more confidently offer a rerepair with the reimplan-
tation technique to selected young patients. As a result,
among the most recent 3 patients needing reoperations for
recurrent AI, rerepair with the reimplantation technique
was performed in 2 cases (Table 3), After 1 and 2 years after
reoperation, these 2 patients have remained free of symp-
toms, with no AI to mild AI.
Study Limitations
One limitation of this study is related to its nonrandom-
ized design from a center where the surgical approach to
BAV has evolved with time to favor the reimplantation tech-
nique. Thus the reimplantation technique was performed
more frequently in recent years, resulting in a shorter
mean duration of follow-up for these patients. Similarly, be-
cause patients with reimplantation underwent operations
more recently, we can assume that they have benefited
from our increased experience with BAV repair relative to
the other group.
CONCLUSIONS
In conclusion, root replacement with the reimplantation
technique stabilizes the functional aortic annulus (VAJ þ
STJ), improves valve mobility (low gradient), and is associ-
ated with improved outcomes in patients undergoing BAV1436 The Journal of Thoracic and Cardiovascular Surrepair. Aggressive root replacement with the reimplantation
technique, even in patients with mild to moderate root dila-
tation (<45 mm), can improve outcomes after BAV repair.
We would like to acknowledge the assistance of our research
nurse, Corinne Coulon, in the preparation of this manuscript.
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DDiscussion
Dr Thomas J. Gleason (Pittsburgh, Pa). I have no disclosures.
First, I congratulate de Kerchove and colleagues for an outstanding
presentation, and I thank them for supplying me with the manu-
script early, as I enjoyed reading it very much.
I strongly agree with the concept that BAV repair in combina-
tion with a reimplantation technique offers the best bicuspid valve
repair. In that context, I have followed Dr El Khoury’s work for the
last many years with great interest, and this study is yet another ex-
ample of his fine skill as a surgeon and his careful review of his
ownwork. These operations can be quite intellectually challenging
with respect to knowing what to do with the cusps and the annulus
and what not to do in a given case, and I commend your group in
doing so with no operative mortality and very low morbidity. Be-
yond these acknowledgements, I have 4 distinct questions, which
perhaps we should address 1 at a time.
Most of the failures were listed as due to cusp prolapse, and the
explanation of insufficiency was explained as a process of delayed
and progressive dilatation at the VAJ, with a mean increase among
the failures of 4.4 mm. If, however, there were simply dilatation of
the VAJ, or, to use Sir Magdi Yacoub’s term, the ‘‘surgical annu-
lus,’’ then it would seem that most patients could undergo rerepair
with reimplantation of the valve. Yet only 2 of the 9 affected pa-
tients underwent subsequent reimplantation. Were there also con-
comitant cusp issues at the time of reoperation, and if so, what
were they?
Dr de Kerchove. Thank you, Dr Gleason, for your very kind
comment and for this first pertinent question. The reoperation after
a previous aortic valve repair is a very different situation from that
of a first aortic valve repair. First, in reoperation, cusp issues may
coexist with VAJ dilatation. For example, in this series, 1 patient
had focal cusp calcification and another required primary repair
with a pericardial patch. In such situations, simple rerepair is ob-
viously contraindicated. Second, at reoperation, patients may be
7 to 10 years older and thus may be better candidates for biopros-
thetic replacement, rather than for valve repair. Third, after a first
repair, patients are not always agreeable to undergo a second re-
pair. And finally, in addition to those cusp or patient issues that
make rerepair feasible or not, we have to recognize that the under-
standing of the mechanism of failure and the confidence within the
reimplantation technique are relatively recent. Rerepair with reim-
plantation was only used twice in the most recent reoperative
cases. With the encouraging early outcomes that we obtainedThe Journal of Thoracic and Carwith those last reoperations, we certainly will continue to propose
reimplantation in cases of repair failure when it is justified.
Dr Gleason. Second, you do not show all of the follow-up
echocardiographic data, giving only the rate of 3+ or greater AI
at late follow-up. How many patients in the 2 groups had 1 or
2+ AI at follow-up, and was there a recurrent pattern of repair ma-
neuver or maneuvers that had a propensity toward recurrent AI of
any degree, be it mild or moderate? I suspect that we could learn
a lot from these data as well. What have you learned about what
other issues, whether cusp, aortic, or technically related, portend
a higher rate of failure beyond simply dilatation of the surgical
annulus?
Dr de Kerchove. This study was designed to compare the clin-
ical outcomes of the 2 groups, and we therefore examined only end
points representative of severe repair failure, a clinical outcome
such as aortic valve reoperation and the recurrence of severe AI.
We didn’t look at the mechanism of AI in patients with mild to
moderate recurrent AI.We built on a Kaplan-Meier curve for mod-
erate or greater recurrent AI, and we observed that the advantage
for the reimplantation group was evenmore statistically significant
by using this end point. This result supports our hypothesis regard-
ing the cause of repair failure in patients without circumferential
ventriculoaortic annuloplasty; however, we agree that it does not
explore the role of other cusp or technical issues in recurrent AI.
We are currently doing echocardiographic studies with this co-
hort of patients in which root dimensions and cusp function are an-
alyzed with time. The objective is to discover the technical or
morphologic factors related to recurrent AI.
Dr Gleason. Third, could you provide us with a bit more detail
with respect to your concept of annuloplasty associated with your
specific reimplantation technique? My interpretation of your de-
scription is that you are placing your primary sutures through
the surgical annulus or the VAJ in a manner similar to what Dr Da-
vid described years ago. I think that this technique is more of an
annular support than an annuloplasty, because one does not neces-
sarily change the anatomic annular shape with this technique.
My own view is that what is critical to a durable repair is the
concomitant correction of the primary angle of the subcommissu-
ral triangle back to a more acute angle, restoring anatomic annular
geometry in cases where there is annuloaortic ectasia of any signif-
icance. In other words, one must reconfigure the anatomic annulus
or the hinge point of the cusps to where they were when the valve
was competent earlier in that patient’s life. Are you changing the
shape of the anatomic annulus in the areas of the subcommissural
triangles with your technique, or are you simply supporting the an-
nulus to prevent subsequent dilatation?
Dr de Kerchove. I agree with you in considering that the reim-
plantation technique provides only a support of the VAJ when only
3 to 6 stitches are used for the proximal suture line. In our tech-
nique, however, the proximal suture line is more like a true annu-
loplasty. Effectively, we kept the original technique and we use 10
to 12 stitches for the proximal suture line. The compression exer-
cised by each stitch induces circumferential remodeling of the
VAJ. The decrease in the VAJ diameter is approximately 5 mm.
It is possible to adjust the remodeling or annuloplasty effect by
adapting the width of the stitches and the strength used to tie
them. For example, in type 0 bicuspid valve, where the valve is
asymmetric, we place the stitches symmetrically under both cuspsdiovascular Surgery c Volume 142, Number 6 1437
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Dto respect the valve morphology. At the opposite extreme, in a type
1 bicuspid valve, where the valve is generally asymmetric with the
conjoint cusp being larger, we place wider stitches under the con-
joint cusp than under the opposite cusp to perform a greater annu-
lar compression at this level. This annuloplasty associated with
symmetric reimplantation of the commissures has 2 advantages
in our opinion. One advantage is that you decrease the tension
on the conjoint cusp, which will facilitate repair of the raphe
and decrease the need for patch augmentation. The second advan-
tage is that you give the valve more symmetry, which seems to im-
prove durability of the repair, as suggested by Dr Sch€afers in
a recent publication.
Dr Gleason. Finally, I am intrigued by your protocol that aims
for a 5-mm coaptation length or depth at the midportion, because,
as you know, the coaptation length of a normal aortic valve and
a normally functioning BAV is nowhere near 5 mm but much
closer to 1 to 2 mm. I suspect that if we aim for a 5-mm coaptation,
likening it to goals of mitral valve repair—that is, that more coap-
tation is better—we will see much more aortic cusp sclerosis with
time along the leading edge, such as you may have seen in the 2
patients who had subsequent development of aortic stenosis at
years 7 and 8. Could you please explain why you do not aim for
a more anatomic correction but rather for this ‘‘overcorrection’’?
Dr de Kerchove. I agree with you regarding the negative im-
pact of overcorrection on repair durability. The 5-mm cutoff length
to which you make reference has been found in an echocardio-
graphic study from our team. In this study, we looked for echocar-
diographic parameters of tricuspid aortic valve and BAV repair
failure. We found that a coaptation length less than 4 mm, the pres-
ence of an eccentric regurgitant jet, and a valve coaptation below
the level of the annulus were independent predictors of late failure.
Currently, we place the greatest importance on the level of coapta-
tion. So if the valve is above the plane of the VAJ and the top of the
coaptation reaches the midpoint of the sinuses of Valsalva, I agree
with you that you don’t need a coaptation length as long as 5 mm.
In some cases, when you end up with some degree of valve billow-
ing, meaning that a portion of the body of the cusp is below the
plane of the VAJ, we think that a 5-mm coaptation provides greater
security for long-term durability, rather than being a sign of pro-
lapse overcorrection.
Dr Gleason. I would argue that the means to eliminate that ex-
act issue would be a proper annuloplasty, and that is really my
point, in that in lieu of a proper annuloplasty, one can create
a more redundant coaptation depth, but this may in fact impart de-
layed failure down the road.1438 The Journal of Thoracic and Cardiovascular SurDr de Kerchove. I agree with you that the role of annuloplasty
is primal.
Dr Michael P. Siegenthaler (Bethesda, Md). Some of your
patients had mild to moderate aortic stenosis after these repairs.
What is the natural history if you look at those patients long
term? Does it stay the same, or do some of them have calcifica-
tion? What was your observation with these mildly stenotic
repaired BAVs?
Dr de Kerchove. For mild or moderate stenosis induced by the
repair, most of the gradients remained stable with time, especially
when patients were young with no cusp calcification at all at the
time of repair. In older patients, or those with calcification at the
time of the repair, the risk of observing progressive increase of gra-
dients is real. At this stage of the follow-up, however, valve steno-
sis represents only 10% of the late failures, and reoperation for
stenosis was performed after 8 years, showing that the valve calci-
fication is a relatively slow process.
Dr Tirone E. David (Toronto, Ontario, Canada). This article is
too important to let go by without a remark. Repair of BAVis much
more complex than repair of tricuspid aortic valve, and those pres-
ent here who do this operation know that. Dr Gleason raised some
very important issues about the annuloplasty. The dilatation of the
aortic annulus is not symmetric. It is almost entirely on the fibrous
skeleton of the outflow tract, and as it dilates, the fibrous skeleton
sinks in on the mitral valve. The level of the false commissure is
thus much higher than the posterior annulus. How do you compen-
sate for that during reimplantation of the aortic valve? Dr El
Khoury, that is a bit unfair to him.
Dr El Khoury. In type 1, I agree that there is a difference in the
level. What we do is we try by sparing surgery first to have a really
180 repair. Now, the second issue is, and I agree with you that we
should see what to do with the false commissure. Now, if you im-
plant it at the same level, you will have a lack of tissue, because the
valvewill be like that [hand gesture]. Sowhy we try to put it a little
bit like that [hand gesture] to have this coaptation at this level. So
we respect it a little bit. But Dr Gleason’s point is very well taken.
If you close the subcommissural triangle, you do this naturally by
making the angle more acute, as opposed to obtuse. In type 1, the
formation of the angle is asymmetric; it is like that [hand gesture].
So we try to make it this way [hand gesture]. But the risk is if you
put it very low, you will have a valve flapping like that [hand ges-
ture]. So we put it a little bit higher to have the same level of
coaptation.
Dr David. He underscores what I said again. It is not a simple
repair; reimplantation of BAV is not simple.gery c December 2011
